Sandip Patel, MD, on Immunotherapy: New Developments and Toxicity Challenges

2017 Palliative Care in Oncology Symposium
Tweet this page

Sandip Patel, MD, of the University of California, San Diego, discusses diagnosing and managing immune-related adverse events from immune checkpoint blockade and the toxicities of these treatments.

Advertisement

Advertisement



Advertisement